Filing Details

Accession Number:
0001127602-15-004354
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-04 16:52:31
Reporting Period:
2015-02-02
Filing Date:
2015-02-04
Accepted Time:
2015-02-04 16:52:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1494892 Frank Haluska C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Svp, Clinical R&D, Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-02 29,334 $0.00 124,633 No 4 M Direct
Common Stock Disposition 2015-02-02 16,134 $6.33 108,499 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2015-02-02 29,334 $0.00 29,334 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
58,666 2024-01-31 No 4 M Direct
Footnotes
  1. Shares were acquired upon vesting of restricted stock units awarded on January 31, 2014.
  2. Represents shares withheld to satisfy witholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
  3. Each restricted stock unit represents a right to receive one share of ARIAD common stock.
  4. The restricted stock units vest as to one-third of the units on each of the first, second and third anniversaries of the date of the award (January 31,2014).
  5. The restricted stock units vested on January 31, 2015.